---
title: "\"Profit Warning\" Junshi Biosciences estimates an annual loss of 873 million RMB, a reduction in loss of 31.9%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274418553.md"
description: "Junshi Biosciences issued a profit warning, expecting a loss of approximately RMB 873 million for the fiscal year 2025, a decrease of 31.85% compared to the previous year. The company aims to enhance its commercialization capabilities and strengthen cost control through the implementation of the \"Quality Improvement and Efficiency Enhancement for Returns\" plan, with an annual operating revenue of approximately RMB 2.5 billion, a year-on-year increase of 28.32%"
datetime: "2026-02-01T10:41:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274418553.md)
  - [en](https://longbridge.com/en/news/274418553.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274418553.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274418553.md) | [繁體中文](https://longbridge.com/zh-HK/news/274418553.md)


# "Profit Warning" Junshi Biosciences estimates an annual loss of 873 million RMB, a reduction in loss of 31.9%

Junshi Biosciences (01877.HK) issued a profit warning, expecting a loss of approximately RMB 873 million for the fiscal year 2025 according to Chinese accounting standards, a decrease of RMB 408 million compared to the previous year, representing a reduction of about 31.85%. This is mainly due to the company's ongoing implementation of the "Quality Improvement and Efficiency Enhancement for Returns" action plan, which has significantly improved commercialization capabilities while continuously strengthening cost control and resource focus.

The total operating revenue for the year is approximately RMB 2.5 billion, an increase of 28.32% year-on-year. This is attributed to the growth in sales revenue from commercialized drugs, as the company continues to expand its global commercialization network

### Related Stocks

- [JUNSHI BIO (01877.HK)](https://longbridge.com/en/quote/01877.HK.md)
- [Junshi Biosciences (688180.CN)](https://longbridge.com/en/quote/688180.CN.md)

## Related News & Research

- [Junshi Biosciences' Loss Narrows in 2025](https://longbridge.com/en/news/277409413.md)
- [Wing Lee Property Warns of Wider Loss in 2025](https://longbridge.com/en/news/277624060.md)
- [Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives](https://longbridge.com/en/news/278175869.md)
- [Hengrui Pharmaceuticals Obtains Nod for Lung Cancer Combo Drug Trials](https://longbridge.com/en/news/277871128.md)
- [Trump on Iran: Have knocked out 10 ships](https://longbridge.com/en/news/277499993.md)